# OnCo record nct05450692 (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/nct05450692/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "nct05450692", "NCT05450692" ;
  schema:name "A Phase III Study of Ceralasertib Plus Durvalumab Versus Docetaxel in Patients With Non Small Cell Lung Cancer (NSCLC) Whose Disease Progressed On or After Prior Anti PD (L)1 Therapy And Platinum Based Chemotherapy"@en ;
  schema:alternateName "LATIFY"@en ;
  schema:description "A phase 3 trial testing Ceralasertib in non-small-cell lung cancer, active and no longer recruiting."@en ;
  schema:url <https://onco.cc/trials/nct05450692/> ;
  schema:dateModified "2026-09-11"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT05450692> ;
  onco:status "active" ;
  onco:tag "ctgov-ingest" ;
  onco:phase "3" ;
  schema:startDate "2022-09-15" ;
  onco:cancers <https://onco.cc/cancers/nsclc/> ;
  onco:drugs <https://onco.cc/drugs/ceralasertib/> ;
  onco:companies <https://onco.cc/companies/astrazeneca/> .